STAT3 and non-small cell lung carcinoma: Yu et al. discovered that in the TME of NSCLC, regonoside VII can block STAT3 phosphorylation by activating the STING/TBK1/IRF3 pathway, promote the polarization of M1-TAM, and potentially up-regulate PD-L1 expression.